Journal profile · CRITICAL CARE MEDICINEMEDICINE, RESEARCH &-MEDICINE, RESEARCH & EXPERIMENTAL
Human Gene Therapy Clinical Development
ISSN 2324-8637 · eISSN 2324-8645 · Mary Ann Liebert Inc. · UNITED STATES
Human Gene Therapy Clinical Development: subscription journal; 0 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Human Gene Therapy Clinical Development is published by Mary Ann Liebert Inc.. By OpenAlex counts of its recent articles, its largest topics are Virus-based gene therapy research, RNA Interference and Gene Delivery and CRISPR and Genetic Engineering, together about 59.3% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes important advances in DNA, RNA, cell and immune therapies, validating the latest advances in research and new technologies.
Source: LetPub
Research area (LetPub): CRITICAL CARE MEDICINEMEDICINE, RESEARCH &-MEDICINE, RESEARCH & EXPERIMENTAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology34.9%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology17.5%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology7%
- Retinal Development and DisordersBiochemistry, Genetics and Molecular Biology3.8%
- Lysosomal Storage Disorders ResearchMedicine3.2%
- Immunotherapy and Immune ResponsesImmunology and Microbiology2.9%
- Biomedical Ethics and RegulationMedicine2.7%
- History of Science and MedicineArts and Humanities2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Genetics (clinical) | Q1 | 21/87 | 76th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 7.2LetPub ·
- SJR 2026-06
- 0.96LetPub ·
- SNIP 2026-06
- 1.06LetPub ·
- h-index
- 16LetPub ·
- h-index
- 41OpenAlex ·
- i10-index
- 104OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 237 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 226 |
| 2025 | 0 | 0 | 364 |
| 2024 | 0 | 0 | 408 |
| 2023 | 0 | 0 | 421 |
| 2022 | 0 | 0 | 440 |
| 2021 | 0 | 0 | 591 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Mary Ann Liebert Inc.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2324-8637
- Electronic ISSN
- 2324-8645
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Human Gene Therapy Clinical Development
Which databases index Human Gene Therapy Clinical Development?
According to LetPub and DOAJ records, Human Gene Therapy Clinical Development is indexed in Scopus.
Is Human Gene Therapy Clinical Development open access, and what is the APC?
Human Gene Therapy Clinical Development is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .